Key metrics and charts across all fundamental categories.
Stock price and market valuation
BMRN trades at $57.35, a 18.9% decrease year-over-year. Market capitalization stands at $11.04B, down 18.2% from the prior year. Track BMRN price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$3.24B in TTM revenue grew 9.9% YoY, reaching $766.21M last quarter. TTM EBITDA of $389.12M on operating income of $129.64M shows growth is flowing through. Net income of $268.74M TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
With $8.59B in assets and $1.43B in long-term debt, the D/E of 0.2 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 41.1x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 3.4x and P/B of 1.8x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.
Operating efficiency and return metrics
Op. margin of 16.9% is down 13.1% YoY — costs are rising relative to revenue. Net margin at 13.8% and gross margin of 74.6%. ROE of 4.3% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $199.73M on $220.65M in operating cash flow. The FCF / Net Income ratio of 0.7x means earnings are well backed by actual cash — high-quality earnings. Cash reserves of $2.22B provide financial flexibility. Share count is stable — no dilution or buyback activity.
